Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate LevoCept™, a Long-Acting Reversible Intrauterine System for Contraceptive Efficacy, Safety, and Tolerability

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04457076
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:46.415102+00:00
Published At
2025-05-22T00:00:00+00:00
Record Updated At
2025-05-22
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Contraception", "Women at Risk for Pregnancy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-22"
protocolSection.identificationModule.nctId
"NCT04457076"
protocolSection.identificationModule.officialTitle
"A Phase 3, Prospective, Multi-Center, Single-Arm, Open-Label Study to Evaluate LevoCept\u2122, a Long-Acting Reversible Intrauterine System for Contraceptive Efficacy, Safety, and Tolerability"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Contraception (protocolSection.conditionsModule.conditions)
  • Women at Risk for Pregnancy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.